Sign inJoin free

Watch / Stock Selection

Defensive plays to navigate tariff tensions

8 May 20257:47

Defensive plays to navigate tariff tensions

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Importance of a defensive investment strategy with unresolved tariffs.

  • Shifts in tech with Apple's potential move from Google to AI alternatives.

  • Opportunities in pharmaceuticals, focusing on GLP-1 weight loss drugs and strategic tariff positioning.

Sam Ruiz from T. Rowe Price shares insights on current market movements amidst unresolved tariffs, suggesting a defensive approach with investments in consumer staples, utilities, and insurance companies. He notes the strength in quarterly earnings, despite looming tariff concerns.

Sam points out changing dynamics in tech, highlighting Apple’s shift from Google to potentially using AI search engines like Perplexity. He mentions his company's decreased exposure to mega-cap tech and increased interest in emerging markets and Europe.

On the pharmaceutical front, Sam sees potential in companies like Eli Lilly (NYSE: LLY) and Shanghai Pharmaceutical (SHA: 601607). He highlights opportunities in GLP-1 weight loss drugs, underscoring the strategic advantage of avoiding US tariffs while tapping into potential royalty streams.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy